Lab Overview

The McDevitt lab is focused on the engineering of innovative technologies to translate the morphogenic potential of stem cells as models of development and disease, as well to develop cellular and molecular therapies aimed to treat degenerative diseases and traumatic injuries. Learn more about the research.

Since stem cells are promising for a number of applications, the emphasis of the McDevitt Lab is on the development of technology platforms to advance therapies that span multiple diseases.

Our technologies are applicable to a wide variety of diseases, including cardiovascular, orthopedic and neurological disorders. Specific diseases that we can apply our research to include treatments for diabetes, chronic wounds, aging, arthritis and other autoimmune disorders. The McDevitt lab's work also has other applications, including wound healing, irritable bowel syndrome, epilepsy and bone regeneration to name just a few. Click here for a complete list of research and disease applications.


  • Overview of Stem Cell Engineering
  • Todd was 1 of 6 panelists that toured Europe and Asia to do an international assessment of the Stem Cell Engineering field.


Gladstone scientists discover how the novel coronavirus damages heart muscle cells, and creates a system that can be used to screen potential therapies
Todd McDevitt and Bruce Conklin comment on COVID-19 cardiac research
This talk was given at the Kickoff Symposium for the iPS Cell Research Center at Gladstone Institutes on February 8, 2021.
The disease may damage cardiac muscle even in those who never displayed symptoms.
Ken Nakamura and Todd McDevitt will study how to boost cells’ energy and how the strategy can best treat disease